Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Until my cancer diagnosis, I did not understand that one future comes at the exclusion of all...

  • “Our lives are unfinished & unfinishable. We do too much, never enough & are done before we’ve even started. We can only pause for a min, clutching our to-do lists, at the precipice of another bounded day. The ache for more…the hardest truth.” #OncTwitter https://t.co/ONDUiFw3Cr - view on twitter

CDC Clinician Outreach and Communication Activity (COCA). Providing clinicians the most current and reliable information on emerging public health threats, such as pandemics, natural...

View detailed information about submitting an abstract including submission categories, guidelines, and policies. Submit an Abstract FEATURED...

It has been reported that ∼15%–25% of patients with hematologic malignancies fail to make anti-spike (anti-S) antibodies in response to full dosing of SARS-CoV-2...

  • Obs study of #COVID19 #vaccine #booster in patients w/ history of B-cell malignancy (N=49): 55% who were seroneg after 2 doses (almost all mRNA) seroconverted after a 3rd dose. Anti-CD20 drug in past 6m = ⬇️ response to 💉. #leusm #lymsm #mmsm #OncTwitter https://t.co/3iSTfMfu6C - view on twitter

A congressional letter is asking NIH to describe the procedures employed for rooting out sexual misconduct committed by advisors. The letter, dated Aug. 9...

The FDA authorized the use of an additional dose of the Pfizer-BioNTech or Moderna COVID-19 Vaccines in certain immunocompromised...

FDA reminds patients and healthcare providers the safety and effectiveness of RAS devices in mastectomy or breast cancer treatment has not been...

Over the past year, I noticed several books written by giants in our field, people everyone knows, people I am honored to know personally....

Key Points. Among people living with HIV, KSHV-MCD is underdiagnosed but treatable if identified, leading to 10-year survival of 71% in this cohort.KSHV-MCD...

ASCO and COA leaders will share the recently published ASCO/COA Oncology Medical Home Standards and recent efforts to promote patient-centered cancer...